Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Clinical trial NCT06498648 · RECRUITING

Trial details

NCT number: NCT06498648
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Dedifferentiated Liposarcoma Advanced Leiomyosarcoma Advanced Soft Tissue Sarcoma Metastatic Dedifferentiated Liposarcoma Metastatic Leiomyosarcoma Metastatic Soft Tissue Sarcoma Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

Start date: 2026-03-18
Primary completion: 2027-01-31
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.